<span item_type="fundamental" item_id="6845dfbbe174fd97244b550a47033fe1" counter_id="ST/US/FTIIU" env="prod"></span><span item_type="announcement" item_id="552357503617991425" env="prod"></span><p>EPS: As of FY2025 Q2, the actual value is USD -0.19.</p><p></p><h3>Segment Revenue</h3><ul><li>The company has not generated any operating revenues as of June 30, 2025, as it is still in the process of identifying a target company for a business combination.<span class="superscript" item_id="0" item_type="announcement_file" value="1" url="https://www.sec.gov/Archives/edgar/data/1889450/000164117225025250/form10-q.htm"></span></li></ul><h3>Operational Metrics</h3><ul><li><strong>Net Income (Loss):</strong> For the three months ended June 30, 2025, the net loss was -$80,647, compared to a net loss of -$44,457 for the same period in 2024. For the six months ended June 30, 2025, the net loss was -$370,320, compared to a net income of $85,119 for the same period in 2024.<span class="superscript" item_id="0" item_type="announcement_file" value="1" url="https://www.sec.gov/Archives/edgar/data/1889450/000164117225025250/form10-q.htm"></span></li><li><strong>Total Expenses:</strong> For the three months ended June 30, 2025, total expenses were $138,735, compared to $284,894 for the same period in 2024. For the six months ended June 30, 2025, total expenses were $592,572, compared to $595,828 for the same period in 2024.<span class="superscript" item_id="0" item_type="announcement_file" value="1" url="https://www.sec.gov/Archives/edgar/data/1889450/000164117225025250/form10-q.htm"></span></li></ul><h3>Cash Flow</h3><ul><li><strong>Operating Cash Flow:</strong> For the six months ended June 30, 2025, net cash used in operating activities was -$1,187,204, compared to -$591,410 for the same period in 2024.<span class="superscript" item_id="0" item_type="announcement_file" value="1" url="https://www.sec.gov/Archives/edgar/data/1889450/000164117225025250/form10-q.htm"></span></li><li><strong>Investing Cash Flow:</strong> For the six months ended June 30, 2025, net cash provided by investing activities was $17,585,764, compared to $36,123,240 for the same period in 2024.<span class="superscript" item_id="0" item_type="announcement_file" value="1" url="https://www.sec.gov/Archives/edgar/data/1889450/000164117225025250/form10-q.htm"></span></li><li><strong>Financing Cash Flow:</strong> For the six months ended June 30, 2025, net cash used in financing activities was -$16,294,605, compared to -$35,548,932 for the same period in 2024.<span class="superscript" item_id="0" item_type="announcement_file" value="1" url="https://www.sec.gov/Archives/edgar/data/1889450/000164117225025250/form10-q.htm"></span></li></ul><h3>Unique Metrics</h3><ul><li><strong>Interest Income:</strong> For the three months ended June 30, 2025, interest income was $72,477, compared to $283,084 for the same period in 2024. For the six months ended June 30, 2025, interest income was $272,304, compared to $819,427 for the same period in 2024.<span class="superscript" item_id="0" item_type="announcement_file" value="1" url="https://www.sec.gov/Archives/edgar/data/1889450/000164117225025250/form10-q.htm"></span></li></ul><h3>Future Outlook and Strategy</h3><ul><li><strong>Core Business Focus:</strong> The company is focused on completing its initial business combination, with a proposed merger with Longevity Biomedical, Inc. The merger is expected to result in the company being renamed Longevity Biomedical, Inc. and listed on NASDAQ under the ticker symbol ‘LBIO’.<span class="superscript" item_id="0" item_type="announcement_file" value="1" url="https://www.sec.gov/Archives/edgar/data/1889450/000164117225025250/form10-q.htm"></span></li><li><strong>Non-Core Business:</strong> The company has extended its business combination deadline multiple times, with the latest extension allowing for a potential combination until August 18, 2026, contingent on monthly deposits into the trust account.<span class="superscript" item_id="0" item_type="announcement_file" value="1" url="https://www.sec.gov/Archives/edgar/data/1889450/000164117225025250/form10-q.htm"></span></li></ul>

FutureTech II Acquisition - UNIT | 10-Q: FY2025 Q2 EPS: USD -0.19